The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Regulatory News (ASHM)

Share Price Information for Ashmore (ASHM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 186.10
Bid: 186.50
Ask: 186.80
Change: 3.20 (1.75%)
Spread: 0.30 (0.161%)
Open: 182.80
High: 187.60
Low: 182.80
Prev. Close: 182.90
ASHM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

13 Oct 2023 07:00

RNS Number : 9900P
Ashmore Group PLC
13 October 2023

Ashmore Group plc13 October 2023

FIRST QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 30 September 2023.

Assets under management

Theme

Actual30 June 2023

(US$ billion)

Estimated30 September 2023

(US$ billion)

Movement

(%)

- External debt

11.0

8.9

-19%

- Local currency

18.8

18.4

-2%

- Corporate debt

6.5

5.5

-15%

- Blended debt

11.9

11.3

-5%

Fixed income

48.2

44.1

-9%

Equities

6.2

6.0

-3%

Alternatives

1.5

1.6

+7%

Total

55.9

51.7

-8%

Assets under management decreased by US$4.2 billion over the period, comprising negative investment performance of US$1.3 billion and net outflows of US$2.9 billion.

Net outflows were at a similar level to the prior quarter, primarily reflecting continuing institutional risk aversion. The outflows were mainly in the external debt and corporate debt themes, with smaller net outflows in blended debt and equities. There were net inflows in the local currency and alternatives themes.

The combination of weaker China economic data and an expectation that developed world interest rates will remain high for longer meant that global capital markets fell over the quarter and the US dollar rallied. While Emerging Markets indices typically declined by 2% to 3% over the three months, this was broadly in line with or marginally better than Developed Markets. As expected in this environment, Ashmore's main fixed income and equity strategies modestly underperformed over the three months.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Emerging Markets were largely rangebound this quarter and overall delivered slightly negative returns. After three quarters of positive returns, such a period of consolidation within a longer recovery cycle is normal, and there continue to be positive fundamental trends in Emerging Markets. For example, central banks in many countries are cutting policy rates in response to falling inflation, which supports the outlook for local bond and equity markets and provides an opportunity to take advantage of lower asset prices. Significantly, India will be included in the main local currency bonds benchmark from mid-2024, illustrating the positive ongoing reforms in emerging countries and providing greater investment diversification. Ashmore continues to deliver longer-term outperformance for clients across a broad range of strategies and is well-positioned to benefit from further recovery in Emerging Markets."

Notes

Local currency AuM includes US$6.6 billion of AuM managed in overlay/liquidity strategies (30 June 2023: US$6.3 billion).

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingNeil Doyle +44 (0)7771 978 220Kit Dunford +44 (0)7717 417 038

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTFLFSRIFLFLIV
Date   Source Headline
18th Apr 20241:11 pmRNSDirectorate Change
15th Apr 20247:00 amRNSTrading Statement
18th Mar 20243:30 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNSTrading Statement
21st Dec 20239:30 amRNSHolding(s) in Company
11th Dec 202311:21 amRNSDirector/PDMR Shareholding
18th Oct 20232:13 pmRNSResult of AGM
13th Oct 20237:00 amRNSTrading Statement
19th Sep 202311:00 amRNSDirector/PDMR Shareholding
19th Sep 202310:08 amRNSHolding(s) in Company
15th Sep 20235:06 pmRNSHolding(s) in Company
14th Sep 20232:56 pmRNSNotice of AGM
14th Sep 202310:29 amRNSDirector/PDMR Shareholding
6th Sep 20237:00 amRNSFinal Results
14th Jul 20231:51 pmRNSHolding(s) in Company
14th Jul 20237:00 amRNSTrading Statement
11th Jul 20232:10 pmRNSHolding(s) in Company
10th Jul 20232:48 pmRNSHolding(s) in Company
30th Jun 20235:11 pmRNSHolding(s) in Company
29th Jun 20239:09 amRNSHolding(s) in Company
14th Jun 20239:23 amRNSHolding(s) in Company
19th May 20238:35 amRNSDirector Declaration
21st Apr 20237:00 amRNSDirectorate Change
17th Apr 20237:00 amRNSTrading Statement
14th Apr 20239:30 amRNSAGM Statement
31st Mar 20232:33 pmRNSDirector/PDMR Shareholding
17th Mar 202310:21 amRNSDirector/PDMR Shareholding
13th Mar 202310:23 amRNSAudit tender process
8th Mar 20239:48 amRNSHolding(s) in Company
27th Feb 20239:41 amRNSHolding(s) in Company
16th Feb 20234:53 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSHalf-year Report
3rd Feb 20233:02 pmRNSHolding(s) in Company
25th Jan 20233:25 pmRNSHolding(s) in Company
24th Jan 20236:12 pmRNSHolding(s) in Company
23rd Jan 20239:01 amRNSHolding(s) in Company
19th Jan 20234:55 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSTrading Statement
12th Jan 20233:26 pmRNSHolding(s) in Company
11th Jan 20234:27 pmRNSHolding(s) in Company
9th Jan 20233:13 pmRNSHolding(s) in Company
5th Jan 20235:14 pmRNSHolding(s) in Company
16th Dec 20223:52 pmRNSHolding(s) in Company
8th Nov 20224:20 pmRNSHolding(s) in Company
28th Oct 202210:13 amRNSHolding(s) in Company
14th Oct 20222:11 pmRNSResult of AGM
14th Oct 20227:00 amRNSTrading Statement
5th Oct 20226:03 pmRNSHolding(s) in Company
23rd Sep 20224:56 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.